DK3219801T3 - Konstruktion - Google Patents
Konstruktion Download PDFInfo
- Publication number
- DK3219801T3 DK3219801T3 DK17161437.3T DK17161437T DK3219801T3 DK 3219801 T3 DK3219801 T3 DK 3219801T3 DK 17161437 T DK17161437 T DK 17161437T DK 3219801 T3 DK3219801 T3 DK 3219801T3
- Authority
- DK
- Denmark
- Prior art keywords
- construction
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C12N15/867—Retroviral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/001—Amines; Imines
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/16—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with reduced pteridine as one donor, and incorporation of one atom of oxygen (1.14.16)
- C12Y114/16002—Tyrosine 3-monooxygenase (1.14.16.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/04—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amidines (3.5.4)
- C12Y305/04016—GTP cyclohydrolase I (3.5.4.16)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
- C12Y401/01—Carboxy-lyases (4.1.1)
- C12Y401/01028—Aromatic-L-amino-acid decarboxylase (4.1.1.28), i.e. tryptophane-decarboxylase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15041—Use of virus, viral particle or viral elements as a vector
- C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/48—Vector systems having a special element relevant for transcription regulating transport or export of RNA, e.g. RRE, PRE, WPRE, CTE
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161552581P | 2011-10-28 | 2011-10-28 | |
| GBGB1118636.8A GB201118636D0 (en) | 2011-10-28 | 2011-10-28 | Nucleotide sequence |
| EP12778779.4A EP2771471B1 (en) | 2011-10-28 | 2012-10-26 | Construct |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3219801T3 true DK3219801T3 (da) | 2021-02-22 |
Family
ID=45373567
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK12778779.4T DK2771471T3 (da) | 2011-10-28 | 2012-10-26 | Konstruktion |
| DK17161437.3T DK3219801T3 (da) | 2011-10-28 | 2012-10-26 | Konstruktion |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK12778779.4T DK2771471T3 (da) | 2011-10-28 | 2012-10-26 | Konstruktion |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11279954B2 (da) |
| EP (2) | EP2771471B1 (da) |
| JP (1) | JP6296987B2 (da) |
| CN (2) | CN107523581B (da) |
| AU (1) | AU2012328166B2 (da) |
| CA (2) | CA2849241C (da) |
| DK (2) | DK2771471T3 (da) |
| ES (2) | ES2628419T3 (da) |
| GB (1) | GB201118636D0 (da) |
| PL (2) | PL3219801T3 (da) |
| WO (1) | WO2013061076A1 (da) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201322798D0 (en) | 2013-12-20 | 2014-02-05 | Oxford Biomedica Ltd | Production system |
| MX2017005834A (es) | 2014-11-05 | 2017-11-17 | Voyager Therapeutics Inc | Polinucleotidos aad para el tratamiento de la enfermedad de parkinson. |
| RU2018104098A (ru) * | 2015-08-03 | 2019-09-06 | Майодопа Лимитед | Системный синтез и регуляция l-дофа |
| GB2562774A (en) * | 2017-05-25 | 2018-11-28 | Mcdonald Michael | Genetic construct |
| JOP20190269A1 (ar) | 2017-06-15 | 2019-11-20 | Voyager Therapeutics Inc | بولي نوكليوتيدات aadc لعلاج مرض باركنسون |
| CN108841868A (zh) * | 2018-05-31 | 2018-11-20 | 康霖生物科技（杭州）有限公司 | 一种用于中枢神经系统疾病治疗的基因序列构建体 |
| JP2022525136A (ja) * | 2019-03-10 | 2022-05-11 | サイオ ジーン セラピーズ インコーポレイテッド | パーキンソン病を処置するための遺伝子治療組成物および方法 |
| CN109971729B (zh) * | 2019-04-19 | 2021-07-16 | 上海信致医药科技有限公司 | 一种酶组合物 |
| GB2587319A (en) | 2019-08-12 | 2021-03-31 | Healing Genes Llc | Genetic construct |
| CN116555351A (zh) * | 2020-03-13 | 2023-08-08 | 康霖生物科技（杭州）有限公司 | 一种核酸构建体 |
| GB2601752A (en) | 2020-12-08 | 2022-06-15 | Maavrx Ltd | Expression vector |
| WO2023111592A1 (en) | 2021-12-17 | 2023-06-22 | Imperial College Innovations Limited | Rna construct |
| CN114317610A (zh) * | 2022-01-27 | 2022-04-12 | 上海本导基因技术有限公司 | 一种适用于帕金森疾病基因治疗的慢病毒载体 |
| CN117106825A (zh) * | 2023-08-28 | 2023-11-24 | 康霖生物科技（杭州）有限公司 | 用于治疗帕金森病的基因治疗载体及其用途 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4797368A (en) | 1985-03-15 | 1989-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | Adeno-associated virus as eukaryotic expression vector |
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| DE4006630A1 (de) | 1990-03-03 | 1991-09-12 | Behringwerke Ag | Humane monoklonale antikoerper gegen tollwutviren, ihre herstellung und verwendung |
| US5512421A (en) | 1991-02-19 | 1996-04-30 | The Regents Of The University Of California | Generation, concentration and efficient transfer of VSV-G pseudotyped retroviral vectors |
| DE69232353T2 (de) | 1991-06-21 | 2002-11-14 | Phillips Petroleum Co | Fluorwasserstoffsäure und Sulfone enthaltender Alkylierungskatalysator |
| US6001650A (en) | 1995-08-03 | 1999-12-14 | Avigen, Inc. | High-efficiency wild-type-free AAV helper functions |
| AU1073797A (en) * | 1995-11-14 | 1997-06-05 | Somatix Therapy Corporation | Joint expression of gtp cyclohydrolase and tyrosine hydroxylase |
| US5866552A (en) | 1996-09-06 | 1999-02-02 | The Trustees Of The University Of Pennsylvania | Method for expressing a gene in the absence of an immune response |
| ES2153654T3 (es) | 1996-10-17 | 2001-03-01 | Oxford Biomedica Ltd | Vectores retrovirales. |
| GB9622500D0 (en) * | 1996-10-29 | 1997-01-08 | Oxford Biomedica Ltd | Therapeutic gene |
| GB9720465D0 (en) | 1997-09-25 | 1997-11-26 | Oxford Biomedica Ltd | Dual-virus vectors |
| GB9803351D0 (en) | 1998-02-17 | 1998-04-15 | Oxford Biomedica Ltd | Anti-viral vectors |
| CN1325653C (zh) | 1998-05-22 | 2007-07-11 | 牛津生物医学（英国）有限公司 | 逆转录病毒传递系统 |
| GB9904905D0 (en) | 1999-03-03 | 1999-04-28 | Oxford Biomedica Ltd | Cells |
| US6857241B1 (en) | 1999-07-13 | 2005-02-22 | Carlos Fradera Pellicer | Building panel and plant for the manufacture thereof |
| GB0009760D0 (en) | 2000-04-19 | 2000-06-07 | Oxford Biomedica Ltd | Method |
| GB0024550D0 (da) * | 2000-10-06 | 2000-11-22 | Oxford Biomedica Ltd | |
| US6723551B2 (en) | 2001-11-09 | 2004-04-20 | The United States Of America As Represented By The Department Of Health And Human Services | Production of adeno-associated virus in insect cells |
| DK1504108T3 (da) | 2002-02-01 | 2013-06-10 | Oxford Biomedica Ltd | Lentivirusvektor |
| SE0302509D0 (sv) | 2003-09-19 | 2003-09-19 | Amersham Biosciences Ab | Matrix for separation of polyethers and method of separation |
| US7943374B2 (en) | 2005-08-21 | 2011-05-17 | Markus Hildinger | Super-size adeno-associated viral vector harboring a recombinant genome larger than 5.7 kb |
| GB0526211D0 (en) | 2005-12-22 | 2006-02-01 | Oxford Biomedica Ltd | Viral vectors |
| GB0526210D0 (en) | 2005-12-22 | 2006-02-01 | Oxford Biomedica Ltd | Vectors |
| US20090214478A1 (en) | 2008-02-21 | 2009-08-27 | Alberto Auricchio | Method of treating ocular diseases by gene therapy |
| CN102124115B (zh) | 2008-06-18 | 2020-03-03 | 牛津生物医学（英国）有限公司 | 病毒纯化 |
| WO2010055290A1 (en) * | 2008-11-11 | 2010-05-20 | Oxford Biomedica (Uk) Limited | Method |
| EP2575894B1 (en) * | 2010-05-28 | 2015-02-25 | Oxford Biomedica (UK) Ltd | Delivery of lentiviral vectors to the brain |
-
2011
- 2011-10-28 GB GBGB1118636.8A patent/GB201118636D0/en not_active Ceased
-
2012
- 2012-10-26 PL PL17161437T patent/PL3219801T3/pl unknown
- 2012-10-26 WO PCT/GB2012/052668 patent/WO2013061076A1/en active Application Filing
- 2012-10-26 PL PL12778779T patent/PL2771471T3/pl unknown
- 2012-10-26 CN CN201710722658.7A patent/CN107523581B/zh active Active
- 2012-10-26 ES ES12778779.4T patent/ES2628419T3/es active Active
- 2012-10-26 EP EP12778779.4A patent/EP2771471B1/en active Active
- 2012-10-26 CN CN201280064927.0A patent/CN104011213B/zh active Active
- 2012-10-26 AU AU2012328166A patent/AU2012328166B2/en active Active
- 2012-10-26 DK DK12778779.4T patent/DK2771471T3/da active
- 2012-10-26 ES ES17161437T patent/ES2857003T3/es active Active
- 2012-10-26 CA CA2849241A patent/CA2849241C/en active Active
- 2012-10-26 DK DK17161437.3T patent/DK3219801T3/da active
- 2012-10-26 JP JP2014537726A patent/JP6296987B2/ja active Active
- 2012-10-26 CA CA3052407A patent/CA3052407C/en active Active
- 2012-10-26 EP EP17161437.3A patent/EP3219801B1/en active Active
-
2019
- 2019-06-26 US US16/454,024 patent/US11279954B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2628419T3 (es) | 2017-08-02 |
| CA2849241C (en) | 2019-12-31 |
| WO2013061076A1 (en) | 2013-05-02 |
| CN107523581B (zh) | 2021-08-17 |
| EP3219801B1 (en) | 2020-12-16 |
| GB201118636D0 (en) | 2011-12-07 |
| JP6296987B2 (ja) | 2018-03-20 |
| ES2857003T3 (es) | 2021-09-28 |
| CA3052407A1 (en) | 2013-05-02 |
| CN104011213B (zh) | 2017-10-03 |
| US20200040361A1 (en) | 2020-02-06 |
| EP2771471A1 (en) | 2014-09-03 |
| CA3052407C (en) | 2020-03-31 |
| EP2771471B1 (en) | 2017-05-03 |
| US11279954B2 (en) | 2022-03-22 |
| AU2012328166A1 (en) | 2014-06-12 |
| CN107523581A (zh) | 2017-12-29 |
| PL3219801T3 (pl) | 2021-06-14 |
| CN104011213A (zh) | 2014-08-27 |
| JP2014532402A (ja) | 2014-12-08 |
| PL2771471T3 (pl) | 2017-10-31 |
| DK2771471T3 (da) | 2017-08-21 |
| CA2849241A1 (en) | 2013-05-02 |
| EP3219801A1 (en) | 2017-09-20 |
| AU2012328166B2 (en) | 2018-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2744810T4 (da) | Tenofovir-alafenamid-hemifumarat | |
| DK2769050T3 (da) | Propsensor | |
| DK3219801T3 (da) | Konstruktion | |
| BR112014000879A2 (pt) | deflegmador | |
| DK3272861T3 (da) | Alpha-galactosidase-sammensætninger | |
| CO6960543A2 (es) | 2-tiopirimidinonas | |
| DE102011100082A8 (de) | Traygreifvorrichtung | |
| DK3141251T3 (da) | Koloskopi - forberedelse | |
| FI20116167L (fi) | Järjestely | |
| DE112011104936A5 (de) | Stanzstauchniet | |
| DE112012000958A5 (de) | Handsäge | |
| DK2476953T3 (da) | Fluidbedkedel | |
| DE112012002458A5 (de) | Hydrotransformator | |
| DE112012000819A5 (de) | Gurtbandfänger | |
| FR2976466B1 (fr) | Etui range-piolet | |
| DE112012005313A5 (de) | Leuchtbild | |
| DK2526750T3 (da) | Høbjærgningsmaskine | |
| DE112012001294T8 (de) | Umspritzungsverfahren | |
| DE102011117169A8 (de) | Absetzplattenanordnung | |
| DE112011105396A5 (de) | Nachverfestigungsverfahren | |
| FI9103U1 (fi) | Rakennelma | |
| UY4068Q (es) | Diseño ositos | |
| DK2681057T3 (da) | Nanofiber-mærkning | |
| UA22810S (uk) | Бідон | |
| ES1076319Y (es) | Minisalvavidas acuatico |